Tas and Ertuk [51] analyzed the prognostic significance of BRAF V600E mutation in 151 stage III patients; a BRAF mutation was present in 51% of melanomas and was associated with better OS and longer disease-free survival. The gene discussed is BRAF; the disease is melanoma.